SCHEMBL30338758

SCHEMBL30338758

c1cncc(-c2c(-n3c4ccccc4c4ccccc43)c(-n3c4ccccc4c4ccccc43)nc(-n3c4ccccc4c4ccccc43)c2-n2c3ccccc3c3ccccc32)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.43
CYP11B1 P15538 2/20 0.42
CYP1A2 P05177 4/20 0.40
CYP3A4 P08684 4/20 0.40
ALDH1A1 P00352 3/20 0.40
CYP2A6 P11509 1/20 0.40
MAPK14 Q16539 1/20 0.40
RAD51 Q06609 1/20 0.40
LCK P06239 1/20 0.39
LMNA P02545 3/20 0.39
CLK4 Q9HAZ1 3/20 0.39
USP2 O75604 2/20 0.39
GBA1 P04062 2/20 0.39
MAPT P10636 1/20 0.39
TSHR P16473 1/20 0.39
MAPK1 P28482 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21889487 1.00 CYP11B2 (0.43) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL22148787 0.93 CYP11B2 (0.41) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL21889548 0.90 CYP11B2 (0.40) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL30339243 0.90 CYP11B2 (0.40) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL30339204 0.90 CYP11B2 (0.40) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL21889549 0.90 CYP11B2 (0.40) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL29995840 0.89 CYP11B2 (0.49) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL20276928 0.89 CYP11B2 (0.49) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL30709266 0.89 CYP11B1 (0.44) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1
SCHEMBL23223249 0.89 CYP11B2 (0.41) CYP11B2CYP11B1CYP1A2CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11555034-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11555034-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 CYP11B2 1254/4885CYP11B1 1985/4885CYP1A2 645/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.